Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 45

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

332

HTML

3082

Figures (1-3)

170

Tables (1-3)

161

Sum=3745

Publishing Process of This Article

Item

Count

Browse

802

Download

800

Sum=1602

Dec 7, 2013 (publication date) through Jul 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 7, 2013; 19(45): 8373-8381
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8373

Full Size Figure Download Figure

Figure 2 Child-Pugh score (A) and sequential change of serum hepatitis B virus DNA level (B) in the course of antiviral therapy over 2 years.

Citation: Li L, Liu W, Chen YH, Fan CL, Dong PL, Wei FL, Li B, Chen DX, Ding HG. Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study. World J Gastroenterol 2013; 19(45): 8373-8381
URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8373.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i45.8373